Description
Recombinant monoclonal antibody to MUC1-C/ECD. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma 8E1.
Target
MUC1-C/ECD
Target Alias Names
MUC1-C/extracellular domain, Mucin-1, MUC-1, Breast carcinoma-associated antigen DF3, Cancer antigen 15-3 (CA 15-3), Carcinoma-associated mucin, Episialin, H23AG, Krebs von den Lungen-6 (KL-6), PEMT, Peanut-reactive urinary mucin (PUM), Polymorphic epithelial mucin (PEM), Tumor-associated epithelial membrane antigen (EMA), Tumor-associated mucin
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression